Abbott Laboratories/ US0028241000 /
| 3/23/2023 3:22:28 PM | Chg. +0.61 | Volume | Bid3:22:54 PM | Ask3:22:54 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 97.48USD | +0.63% | 26,905 Turnover: 2.62 mill. |
97.46Bid Size: 300 | 101.93Ask Size: 162 | 168.79 bill.USD | 1.98% | 24.65 |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 3.94 USD | -0.76% |
| EPS Diluted: | 3.91 USD | -0.76% |
| Revenues per Share: | 25.12 USD | 2.83% |
| Book Value per Share: | 21.23 USD | 3.95% |
| Cash Flow per Share: | 5.51 USD | -7.70% |
| Dividend per Share: | 1.92 USD | 5.49% |
| Total | in mill. | |
| Revenues: | 43,653.00 USD | 1.34% |
| Net Income: | 6,933.00 USD | -1.95% |
| Operating Cash Flow: | 9,581.00 USD | - |
| Cash and Cash Equivalents: | 9,882.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 24.65 | 27.87 |
| P/S Ratio: | 3.87 | 4.37 |
| P/BV ratio: | 4.57 | 5.17 |
| P/CF Ratio: | 17.62 | 19.92 |
| PEG: | -32.62 | -36.88 |
| Earnings Yield: | 4.06% | 3.59% |
| Dividend Yield: | 1.98% | 1.75% |
| Market Capitalization | ||
| Market Capitalization: | 168.79 bill. USD | 190.81 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 1.74 bill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | 19.16% |
| Net Profit Margin: | 15.88% |
| Return on Equity: | 18.79% |
| Return on Assets: | 9.31% |
Financial Strength
| Liquidity I / Cash Ratio: | 63.80% |
| Liquidity II / Quick Ratio: | 103.94% |
| Liquidity III / Current Ratio: | 162.85% |
| Debt / Equity Ratio: | 101.70% |
| Dynam. Debt / Equity Ratio: | 391.74% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 12/31/2022 |
| Accounting Standard: | US GAAP |
| Currency: | USD |